Dec. 7, 2021 Sharon Fima, CEO and CTO, MeaTech3D:
“Today’s breakthrough is the culmination of over one year’s efforts in our cellular biology and high-throughput tissue engineering processes, as well as our precision bioprinting technology. By bioprinting a 3.67 oz steak comprised of living tissue, we believe we have both validated our core technologies and...
This stock has been in a falling triangle for a long time, I't broke down under i'ts previously set support line, tested 3-5 times before, of around 5.50 and went into a free fall to test previous lows. We are now seeing a possible retrace if it can break through 5.50 and breaking the falling resistance would make this stock an absolute BUY.